Twitter

11/3/2009 - Merck & Co. (NYSE:MRK) is set to complete the $41 billion acquisition of Schering-Plough Corp. (NYSE:SGP) later Tuesday. The acquisition will create the second-largest drugmaker, behind Pfizer (NYSE:PFE). The deal is expected to close after the end of trading day Tuesday. The completion comes after the FTC approved the deal on Thursday, after the companies received approval from the EU and shareholders. The companies have been jointly selling the cholesterol drugs Vytorin and Zetia for years.

Contact Chip Brian

SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.

Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at www.TradeTheTrend.com/signup.html